Company Filing History:
Years Active: 2016-2025
Title: Tomomi Ide: Innovator in Therapeutic Drug Development
Introduction
Tomomi Ide is a prominent inventor based in Fukuoka, Japan. She has made significant contributions to the field of therapeutic drug development, particularly in addressing lipid-peroxidation-induced diseases. With a total of 5 patents to her name, her work has the potential to impact various medical treatments.
Latest Patents
Among her latest patents, Ide has developed a therapeutic drug for lipid-peroxidation-induced diseases and a screening method for such drugs. This invention provides an assay method that utilizes a compound represented by formula (I) as a fluorescent probe molecule. It is designed to detect the lipid peroxidation suppression activity of a test compound. Additionally, she has created an assay kit that employs this method, along with a pharmaceutical composition aimed at treating diseases like age-related macular degeneration, which are induced by lipid peroxidation reactions.
Another notable patent involves detection reagents and kits for identifying the oxidized and glycated states of low-density lipoproteins. This detection reagent allows for comprehensive detection of both states, utilizing a fluolophore-labelled antibody to identify oxidized low-density lipoproteins and a fluorescent nitroxide for lipid radicals.
Career Highlights
Throughout her career, Tomomi Ide has worked with various companies, including Fuso Pharmaceutical Industries, Ltd. Her innovative approaches and dedication to research have established her as a key figure in her field.
Collaborations
Ide has collaborated with notable colleagues such as Ken-ichi Yamada and Keiichi Yamamoto. These partnerships have further enhanced her research and development efforts.
Conclusion
Tomomi Ide's contributions to therapeutic drug development highlight her innovative spirit and commitment to addressing critical health issues. Her patents reflect her expertise and the potential for significant advancements in medical treatments.